|
1
|
McKinsey TA and Kass DA: Small-molecule
therapies for cardiac hypertrophy: Moving beneath the cell surface.
Nat Rev Drug Discov. 6:617–635. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kumar A, Kaur H, Devi P and Mohan V: Role
of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and
Meniere-like syndrome. Pharmacol Ther. 124:259–268. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crane FL: Discovery of ubiquinone
(coenzyme Q) and an overview of function. Mitochondrion. 7
Suppl:S2–S7. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bentinger M, Tekle M and Dallner G:
Coenzyme Q-biosynthesis and functions. Biochem Biophys Res Commun.
396:74–79. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saha SP and Whayne TF Jr: Coenzyme Q-10 in
human health: Supporting evidence? South Med J. 109:17–21. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kocharian A, Shabanian R, Rafiei-Khorgami
M, Kiani A and Heidari-Bateni G: Coenzyme Q10 improves diastolic
function in children with idiopathic dilated cardiomyopathy.
Cardiol Young. 19:501–506. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huynh K, Kiriazis H, Du XJ, Love JE,
Jandeleit-Dahm KA, Forbes JM, McMullen JR and Ritchie RH: Coenzyme
Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and
cardiac fibrosis in the db/db mouse model of type 2 diabetes.
Diabetologia. 55:1544–1553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Navas P, Villalba JM and de Cabo R: The
importance of plasma membrane coenzyme Q in aging and stress
responses. Mitochondrion. 7 Suppl:S34–S40. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Alp NJ and Channon KM: Regulation of
endothelial nitric oxide synthase by tetrahydrobiopterin in
vascular disease. Arterioscler Thromb Vasc Biol. 24:413–420. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Forsgren M, Attersand A, Lake S, Grünler
J, Swiezewska E, Dallner G and Climent I: Isolation and functional
expression of human COQ2, a gene encoding a polyprenyl transferase
involved in the synthesis of CoQ. Biochem J. 382:519–526. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bentinger M, Tekle M, Brismar K, Chojnacki
T, Swiezewska E and Dallner G: Stimulation of coenzyme Q synthesis.
Biofactors. 32:99–111. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kalén A, Appelkvist EL, Chojnacki T and
Dallner G: Nonaprenyl-4-hydroxybenzoate transferase, an enzyme
involved in ubiquinone biosynthesis, in the endoplasmic
reticulum-Golgi system of rat liver. J Biol Chem. 265:1158–1164.
1990.PubMed/NCBI
|
|
13
|
Fulton D, Fontana J, Sowa G, Gratton JP,
Lin M, Li KX, Michell B, Kemp BE, Rodman D and Sessa WC:
Localization of endothelial nitric-oxide synthase phosphorylated on
serine 1179 and nitric oxide in Golgi and plasma membrane defines
the existence of two pools of active enzyme. J Biol Chem.
277:4277–4284. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsai KL, Huang YH, Kao CL, Yang DM, Lee
HC, Chou HY, Chen YC, Chiou GY, Chen LH, Yang YP, et al: A novel
mechanism of coenzyme Q10 protects against human endothelial cells
from oxidative stress-induced injury by modulating NO-related
pathways. J Nutr Biochem. 23:458–468. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McGarvey TW, Nguyen T, Puthiyaveettil R,
Tomaszewski JE and Malkowicz SB: TERE1, a novel gene affecting
growth regulation in prostate carcinoma. Prostate. 54:144–155.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakagawa K, Hirota Y, Sawada N, Yuge N,
Watanabe M, Uchino Y, Okuda N, Shimomura Y, Suhara Y and Okano T:
Identification of UBIAD1 as a novel human menaquinone-4
biosynthetic enzyme. Nature. 468:117–121. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hirota Y, Tsugawa N, Nakagawa K, Suhara Y,
Tanaka K, Uchino Y, Takeuchi A, Sawada N, Kamao M, Wada A, et al:
Menadione (vitamin K3) is a catabolic product of oral phylloquinone
(vitamin K1) in the intestine and a circulating precursor of tissue
menaquinone-4 (vitamin K2) in rats. J Biol Chem. 288:33071–33080.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mugoni V, Postel R, Catanzaro V, De Luca
E, Turco E, Digilio G, Silengo L, Murphy MP, Medana C, Stainier DY,
et al: Ubiad1 is an antioxidant enzyme that regulates eNOS activity
by CoQ10 synthesis. Cell. 152:504–518. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McGarvey TW, Nguyen T, Tomaszewski JE,
Monson FC and Malkowicz SB: Isolation and characterization of the
TERE1 gene, a gene down-regulated in transitional cell carcinoma of
the bladder. Oncogene. 20:1042–1051. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hegarty JM, Yang H and Chi NC:
UBIAD1-mediated vitamin K2 synthesis is required for vascular
endothelial cell survival and development. Development.
140:1713–1719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakagawa K, Sawada N, Hirota Y, Uchino Y,
Suhara Y, Hasegawa T, Amizuka N, Okamoto T, Tsugawa N, Kamao M, et
al: Vitamin K2 biosynthetic enzyme, UBIAD1 is essential for
embryonic development of mice. PLoS One. 9:e1040782014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cooper SA, Whaley-Connell A, Habibi J, Wei
Y, Lastra G, Manrique C, Stas S and Sowers JR:
Renin-angiotensin-aldosterone system and oxidative stress in
cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol.
293:H2009–H2023. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakashima H, Suzuki H, Ohtsu H, Chao JY,
Utsunomiya H, Frank GD and Eguchi S: Angiotensin II regulates
vascular and endothelial dysfunction: Recent topics of Angiotensin
II type-1 receptor signaling in the vasculature. Curr Vasc
Pharmacol. 4:67–78. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Olivares-Reyes JA, Arellano-Plancarte A
and Castillo-Hernandez JR: Angiotensin II and the development of
insulin resistance: Implications for diabetes. Mol Cell Endocrinol.
302:128–139. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Carvalheira JB, Calegari VC, Zecchin HG,
Nadruz W Jr, Guimarães RB, Ribeiro EB, Franchini KG, Velloso LA and
Saad MJ: The cross-talk between angiotensin and insulin
differentially affects phosphatidylinositol 3-kinase- and
mitogen-activated protein kinase-mediated signaling in rat heart:
Implications for insulin resistance. Endocrinology. 144:5604–5614.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Habibi J, Whaley-Connell A, Hayden MR,
DeMarco VG, Schneider R, Sowers SD, Karuparthi P, Ferrario CM and
Sowers JR: Renin inhibition attenuates insulin resistance,
oxidative stress, and pancreatic remodeling in the transgenic Ren2
rat. Endocrinology. 149:5643–5653. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koh KK, Quon MJ, Lee Y, Han SH, Ahn JY,
Chung WJ, Kim JA and Shin EK: Additive beneficial cardiovascular
and metabolic effects of combination therapy with ramipril and
candesartan in hypertensive patients. Eur Heart J. 28:1440–1447.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lastra G, Whaley-Connell A, Manrique C,
Habibi J, Gutweiler AA, Appesh L, Hayden MR, Wei Y, Ferrario C and
Sowers JR: Low-dose spironolactone reduces reactive oxygen species
generation and improves insulin-stimulated glucose transport in
skeletal muscle in the TG(mRen2)27 rat. Am J Physiol Endocrinol
Metab. 295:E110–E116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin LY, Lin CY, Su TC and Liau CS:
Angiotensin II-induced apoptosis in human endothelial cells is
inhibited by adiponectin through restoration of the association
between endothelial nitric oxide synthase and heat shock protein
90. FEBS Lett. 574:106–110. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Landmesser U, Engberding N, Bahlmann FH,
Schaefer A, Wiencke A, Heineke A, Spiekermann S, Hilfiker-Kleiner
D, Templin C, Kotlarz D, et al: Statin-induced improvement of
endothelial progenitor cell mobilization, myocardial
neovascularization, left ventricular function, and survival after
experimental myocardial infarction requires endothelial nitric
oxide synthase. Circulation. 110:1933–1939. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Langsjoen PH, Langsjoen A, Willis R and
Folkers K: Treatment of hypertrophic cardiomyopathy with coenzyme
Q10. Mol Aspects Med. 18 Suppl:S145–S151. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lakó-Futó Z, Szokodi I, Sármán B, Földes
G, Tokola H, Ilves M, Leskinen H, Vuolteenaho O, Skoumal R,
deChâtel R, et al: Evidence for a functional role of angiotensin II
type 2 receptor in the cardiac hypertrophic process in vivo in the
rat heart. Circulation. 108:2414–2422. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Orr A, Dubé MP, Marcadier J, Jiang H,
Federico A, George S, Seamone C, Andrews D, Dubord P, Holland S, et
al: Mutations in the UBIAD1 gene, encoding a potential
prenyltransferase, are causal for Schnyder crystalline corneal
dystrophy. PLoS One. 2:e6852007. View Article : Google Scholar : PubMed/NCBI
|
